Advocacy & policy
A collective voice for sustainable medicine supply.
PLASA brings pharmaceutical logistics experience into discussions affecting regulation, distribution economics and access to medicines.

Our approach
Industry experience. Constructive engagement.
We connect practical supply-chain knowledge with policy dialogue, working with members and relevant stakeholders to identify challenges and develop considered responses.
- Represent shared industry concerns.
- Support informed policy and regulatory engagement.
- Encourage collaboration across the healthcare supply chain.
- Communicate developments and opportunities for member participation.
Priority themes
Issues that shape patient access.
01
Pricing & logistics remuneration
South Africa’s regulated Single Exit Price (SEP), including its logistics fee, shapes medicine distribution economics. PLASA brings the cost of compliant storage, distribution, working capital and continuity of supply into policy discussions.
02
NHI & supply-chain capability
The National Health Insurance Act 20 of 2023 makes supply-chain capability a central policy issue. PLASA supports dialogue on dependable medicine supply, distribution infrastructure and public–private coordination.
03
Medicine availability
Encouraging earlier visibility, communication and collaboration on shortages and continuity of supply.
04
Regulatory clarity
Bringing operational experience into discussions on licensing, compliance and distribution requirements.
05
Skills & innovation
Supporting sector capability, responsible technology adoption and knowledge-sharing.
06
Regional collaboration
Connecting stakeholders across South Africa and Sub-Saharan Africa.
Participate
Bring your experience to the conversation.
Members can identify shared challenges and express interest in contributing to relevant industry discussions.
Advocacy record
The work behind the dialogue.
Historical PLASA articles record engagement with the SAPC on Board Notice 50 and cold-chain requirements, collaboration on rural vaccine distribution, and participation in the Codeine Care initiative. These are historical accounts, not statements of current regulatory outcomes.
Read the historical record · Forum principles
Information shared through PLASA is vetted for suitability and potential collusion risks. Where member opinions differ, the differing positions are clearly distinguished and presented separately.